Interestingly, we did not find any significant association between TP53 mutations and mRNA expression of selected targets: BAX, PUMA, CDKN1A, and CDKN2A. In the light of the recent work by (73) this finding is in line with the HNSCC expression profile. Here, BAX is linked to head and neck squamous cell carcinoma.